S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 29 of 29

Issue Date	Title / Author(s) / Citation	File
2008-05	Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines Kim, Min Jung; Lee, June-Chul; Lee, Jae-Jung; Kim, Soyeon; Lee, Sang Goo; Park, Seok-Woo; Sung, Myung Whun; Heo, Dae Seog Tumour Biol. 2008;29(1):28-34. Epub 2008 May 23.	link
2008-06	Investigation on health effects of an abandoned metal mine Kim, Soyeon; Kwon, Ho-Jang; Cheong, Hae-Kwan; Choi, Kyungho; Jang, Jae-Yeon; Jeong, Woo-Chul; Kim, Dae-Seon; Yu, Seungdo; Kim, Young-Wook; Lee, Kwang-Young; Yang, Seoung-Oh; Jhung, Ik Jae; Yang, Won-Ho; Hong, Yun-Chul J Korean Med Sci. 2008; 23(3): 452-8	view file DOI
2011-09	Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Soyeon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Kim, Woo-Ho; Kim, Young Tae; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.9, pp.1474-1480	DOI
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2015-01	In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Anticancer Research, Vol.35 No.1, pp.175-182
2015-05	Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog Clinical Cancer Research, Vol.21 No.10, pp.2379-2387	DOI
2015-11	Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells Oh, Se Jin; Noh, Kyung Hee; Lee, Young-Ho; Hong, Soon-Oh; Song, Kwon-Ho; Lee, Hyo-Jung; Kim, Soyeon; Kim, Tae Min; Jeon, Ju-Hong; Seo, Jae Hong; Kim, Dong-Wan; Kim, Tae Woo Oncotarget, Vol.6 No.37, pp.40255-40267	view file DOI
2015-12	Mechanisms of Acquired Resistance to AZD9291 A Mutation-Selective, Irreversible EGFR Inhibitor Kim, Tae Min; Song, Ahnah; Kim, Dong-Wan; Kim, Soyeon; Ahn, Yong-Oon; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.12, pp.1736-1744	DOI
2017-05	Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type Sim, Sung Hoon; Kim, Soyeon; Kim, Tae Min; Jeon, Yoon Kyung; Nam, Soo Jeong; Ahn, Yong-Oon; Keam, Bhumsuk; Park, Hyun Ho; Kim, Dong-Wan; Kim, Chul Woo; Heo, Dae Seog American Journal of Pathology, Vol.187 No.5, pp.980-986	DOI
2017-06	Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma Ock, Chan-Young; Kim, Sehui; Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Chung, Eun-Jae; Kim, Jin-Ho; Kim, Tae Min; Kwon, Seong Keun; Jeon, Yoon Kyung; Jung, Kyeong Chun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung Whun; Heo, Dae Seog Oncotarget, Vol.8 No.58, pp.97920-97927	view file DOI
2017-09	Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas Lee, June-Koo; Lee, Junehawk; Kim, Sehui; Kim, Soyeon; Youk, Jeonghwan; Park, Seongyeol; An, Yohan; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog; Kim, Young Tae; Kim, Jin-Soo; Kim, Se Hyun; Lee, Jong Seok; Lee, Se-Hoon; Park, Keunchil; Ku, Ja-Lok; Jeon, Yoon Kyung; Chung, Doo Hyun; Park, Peter J.; Kim, Joon; Kim, Tae Min; Ju, Young Seok Journal of Clinical Oncology, Vol.35 No.26, pp.3065-3074	DOI
2019-06	NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors Park, Ha-Ram; Ahn, Yong-Oon; Kim, Tae Min; Kim, Soyeon; Kim, Seulki; Lee, Yu Soo; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog Cytotherapy, Vol.21 No.6, pp.603-611	DOI
2019-07	Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer Kim, Su-Jung; Kim, Soyeon; Kim, Dong-Wan; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Lee, Yusoo; Koh, Jaemoon; Jeon, Yoon Kyung; Heo, Dae Seog Cancer Research and Treatment, Vol.51 No.3, pp.1231-1240	view file DOI
2019-07	Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib Kim, Seulki; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Alm, Yong-Oon; Keam, Bhumsuk; Heo, Dae Seog Cancer Research and Treatment, Vol.51 No.3, pp.951-962	view file DOI
2019-08	Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study Jung, Minsun; Kim, Soyeon; Lee, June-Koo; Yoon, Sun Och; Park, Heae Surng; Hong, Soon Won; Park, Weon-Seo; Kim, Ji Eun; Kim, Joon; Keam, Bhumsuk; Kim, Hyun Jik; Kang, Hyoung Jin; Kim, Dong-Wan; Jung, Kyeong Cheon; Kim, Young Tae; Heo, Dae Seog; Kim, Tae Min; Jeon, Yoon Kyung Oncologist, Vol.24 No.8, pp.E740-E748	DOI
2019-09	Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations Lee, Yusoo; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Ku, Ja-Lok; Heo, Dae Seog Journal of Thoracic Oncology, Vol.14 No.9, pp.1556-1566	DOI
2020-05	Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people aged 66 years in South Korea Lee, Yeong Chan; Kang, Jae Myeong; Lee, Hyewon; Kim, Kiwon; Kim, Soyeon; Yu, Tae Yang; Lee, Eun-Mi; Kim, Clara T; Kim, Doh Kwan; Lewis, Matthew; Won, Hong-Hee; Jessen, Frank; Myung, Woojae Alzheimer's Research & Therapy. 2020 May 06;12(1):52	view file DOI
2020-09	Associations between vascular risk factors and subsequent Alzheimers disease in older adults Lee, Hyewon; Kim, Kiwon; Lee, Yeong Chan; Kim, Soyeon; Won, Hong-Hee; Yu, Tae Yang; Lee, Eun-Mi; Kang, Jae Myeong; Lewis, Matthew; Kim, Doh Kwan; Myung, Woojae Alzheimer's Research & Therapy. 2020 Sep 26;12(1):117	view file DOI
2020-12	Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells Park, Siyeon; Kim, Tae Min; Cho, Sung-Yup; Kim, Soyeon; Oh, Yumi; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog Cancer Letters, Vol.495, pp.135-144	DOI
2021-10	Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment Oh, So Yeon; Kim, Soyeon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Scientific Reports, Vol.11 No.1, p. 19712
2021-11	Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR(T790M)-Mutant NSCLC Park, Ha-Ram; Kim, Tae Min; Lee, Yusoo; Kim, Soyeon; Park, Seongyeol; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog Journal of Thoracic Oncology, Vol.16 No.11, pp.1859-1871	DOI
2022-01	Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer Lee, Chaelin; Kim, Miso; Kim, Dong-Wan; Kim, Tae Min; Kim, Soyeon; Im, Sun-Wha; Jeon, Yoon Kyung; Keam, Bhumsuk; Ku, Ja-Lok; Heo, Dae Seog Cancer Research and Treatment, Vol.54 No.1, pp.140-149	DOI
2022-04	Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types Seo, Ha-Young; Kim, Soon-Chan; Roh, Woo-lee; Shin, Young-Kyoung; Kim, Soyeon; Kim, Dong-Wan; Kim, Tae Min; Ku, Ja-Lok Scientific Reports, Vol.12 No.1, p. 6345	DOI
2022-07	Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis Park, Ha-Ram; Kim, Seong-Eun; Keam, Bhumsuk; Chung, Hyewon; Seok, Seung Hyeok; Kim, Soyeon; Kim, Miso; Kim, Tae Min; Doh, Junsang; Kim, Dong-Wan; Heo, Dae Seog Scientific Reports, Vol.12 No.1, p. 12546	DOI
2022-08	Effect of a nutritional support protocol on enteral nutrition and clinical outcomes of critically ill patients: a retrospective cohort study Park, Heemoon; Lim, Sung Yoon; Kim, Sebin; Kim, Hyung-Sook; Kim, Soyeon; Yoon, Ho Il; Cho, Young-Jae Acute and Critical Care, Vol.37 No.3, pp.382-390	DOI
2023-01	The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines Lee, Jeongjae; Keam, Bhumsuk; Kim, Soyeon; Heo, Jung-Nyoung; Joung, Eunkyo; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Translational Oncology, Vol.27, p. 101592	DOI
2023-06	Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance Kim, Jung Sun; Kim, Soyeon; Koh, Jaemoon; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Lindmark, Bertil; Kim, Dong-Wan Journal of Cancer Research and Clinical Oncology, Vol.149 No.6, pp.2355-2365	DOI
2023-10	Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Kim, Miso; Kim, Soyeon; Yim, Jeemin; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog Cancer Research and Treatment, Vol.55 No.4, pp.1134-1143	DOI